0001192482-19-000499.txt : 20191209
0001192482-19-000499.hdr.sgml : 20191209
20191209183859
ACCESSION NUMBER: 0001192482-19-000499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191209
DATE AS OF CHANGE: 20191209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashton William
CENTRAL INDEX KEY: 0001474553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 191276275
MAIL ADDRESS:
STREET 1: C/O HARRISON CONSULTING GROUP
STREET 2: PO BOX 283
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-12-05
0001588972
Recro Pharma, Inc.
REPH
0001474553
Ashton William
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN,
PA
19355
1
0
0
0
Common Stock
2019-12-05
4
A
0
17582
0
A
44994
D
These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company.
/s/ Ryan D. Lake, Attorney-in-fact
2019-12-09